Q2 2025 Holdings
Filed 2025-08-14 | 71 holdings | $100.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Accelerate Diagnostics Inc | COM | 00430H102 | $2.1K | 325,239 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $19.7K | 17,000 | 0.0% |
| Alumis Inc(ALMS) | COM | 022307102 | $30.0K | 10,000 | 0.0% |
| Aptevo Therapeutics Inc | COM NEW | 03835L405 | $30.5K | 10,000 | 0.0% |
| Inflarx NV(IFRX) | COM | N44821101 | $39.5K | 50,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $61.6K | 28,800 | 0.1% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $87.1K | 280,000 | 0.1% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $120.6K | 27,985 | 0.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $150.6K | 20,000 | 0.1% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $159.9K | 16,500 | 0.2% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $160.4K | 28,000 | 0.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $170.0K | 138,176 | 0.2% |
| Neuropace Inc(NPCE) | COM | 641288105 | $183.2K | 16,442 | 0.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $215.9K | 5,000 | 0.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $239.8K | 25,000 | 0.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $242.3K | 14,000 | 0.2% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $254.8K | 22,000 | 0.3% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $262.0K | 40,300 | 0.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $287.2K | 40,000 | 0.3% |
| Tela BIO Inc(TELA) | COM | 872381108 | $300.7K | 155,000 | 0.3% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $303.6K | 60,000 | 0.3% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $330.4K | 10,000 | 0.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $346.1K | 2,700 | 0.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $358.4K | 40,000 | 0.4% |
| Alphatec Holdings Inc(ATEC) | COM | 02081G201 | $366.3K | 33,000 | 0.4% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $377.6K | 8,000 | 0.4% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $458.2K | 32,110 | 0.5% |
| Pacific Biosciences Calif Inc(PACB) | COM | 69404D108 | $496.0K | 400,000 | 0.5% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $520.2K | 10,000 | 0.5% |
| Xencor Inc(XNCR) | COM | 98401F105 | $550.2K | 70,000 | 0.5% |
| Immunome Inc(IMNM) | COM | 45257U108 | $558.0K | 60,000 | 0.6% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $558.5K | 26,000 | 0.6% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $562.8K | 60,000 | 0.6% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $566.7K | 16,000 | 0.6% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $570.8K | 134,000 | 0.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $626.3K | 6,000 | 0.6% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $654.5K | 18,000 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $657.3K | 21,000 | 0.7% |
| Outset Medical Inc(OMGBP) | COM | 690145107 | $664.4K | 34,584 | 0.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $694.9K | 16,000 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONS ADR | 86366E106 | $746.6K | 36,000 | 0.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $757.4K | 67,000 | 0.8% |
| Freeport-Mcmoran CL(FCX) | CL-B | 35671D857 | $781.7K | 18,033 | 0.8% |
| Kiniksa Pharmaceuticals LTD | COM | G5269C101 | $830.1K | 30,000 | 0.8% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $870.6K | 178,768 | 0.9% |
| Treace Medical Concepts Inc(TMCI) | COM | 89455T109 | $1.0M | 176,947 | 1.0% |
| Docgo Inc(DCGO) | COM | 256086109 | $1.2M | 764,062 | 1.2% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $1.2M | 4,250 | 1.2% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.4M | 98,697 | 1.4% |
| Masimo Corp(MASI) | COM | 574795100 | $1.4M | 8,280 | 1.4% |